Last updated: April 3, 2024
Sponsor: University Malaysia Sarawak
Overall Status: Active - Recruiting
Phase
N/A
Condition
Anesthesia
Treatment
Ultrasound-guided scalp block with ropivacaine 0.375%
Ultrasound-guided scalp block with placebo
Clinical Study ID
NCT06127628
NMRR ID-23-03179-N5K
Ages > 18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- All American Society of Anesthesia class I to III patients undergoing electivesupratentorial craniotomies under general anaesthesia.
Exclusion
Exclusion Criteria:
- Refusal to participate in the study
- Contraindications to the performance of scalp block, such as local infections
- Allergy to ropivacaine hydrochloride
- Age < 18 years old
- Undergoing emergency craniotomies, posterior fossa surgery, or burr holes surgery
- Pre-existing chronic pain (defined as persistent or recurrent pain lasting > 3 months)
- History of drug addiction (illicit substances and opioids use) or chronic alcoholabuse
- Presence of uncontrolled systemic arterial hypertension, severe cardiovasculardisease, severe kidney or severe liver diseases
- Predicted to require postoperative ventilation in the intensive care unit
- Psychiatric disorders, serious neurological diseases, or reduced consciousness GCS < 14
Study Design
Total Participants: 60
Treatment Group(s): 2
Primary Treatment: Ultrasound-guided scalp block with ropivacaine 0.375%
Phase:
Study Start date:
April 01, 2024
Estimated Completion Date:
October 31, 2025
Study Description
Connect with a study center
Sarawak General Hospital
Kuching, Sarawak 93586
MalaysiaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.